Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Overview of Plasmapheresis MarketThe Global Plasmapheresis Market is valued at USD 1.34 Billion in 2024 and is projected to attain a value of USD 2.97 Billion by 2035 at a CAGR of 7.55% during the ...

Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.

Circulate Health, a Seattle health longevity startup, today announced $12 million in seed funding to expand its plasma ...

Since the emergence of the Zika virus epidemic in 2014 and the associated novel sequalae that emerged, much has been learned about the effects of antenatal exposure to Zika virus. Zika virus in ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Following reports of Guillain-Barré Syndrome (GBS) cases, the Navi Mumbai Municipal Corporation (NMMC) has appealed to citizens not to panic and to seek immediate medical attention at municipal ...

Of all the autoimmune diseases out there, Guillain-Barre syndrome is definitely one of the less common. This condition, which affects the body's nerves and causes muscle weakness that develops into ...

Mysuru: Following the state govt's move to form an expert committee to investigate a surge in sudden cardiac deaths, ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Multiple sclerosis affects everyone differently. Learn what experts currently know about possible multiple sclerosis causes and risk factors, such as the immune system.